Skip to content
Menu

Eton Pharmaceuticals, Inc. ETON

Full chart Compare
Set alert

Price alert · ETON

All alert types
61.36 USD -0.63 (-1.02%)

Regular-session close

61.20 -0.16 -0.26%

Pre-market · Nov 20, 5:15 AM ET

61.07 Day range 63.38
14.27 52-week range 70.64
YTD
+262.86%
1 year
+264.80%

5D -0.44 (-0.71%)

626466FriMonTueWedThu61.36
Market cap
1.77B
Revenue (ttm)
141.06M
Profit margin
35.35%
EPS (ttm)
1.54
Shares out
28.84M
P/E ratio
39.84
Forward P/E
18.57
YTD return
+262.86%
1-year return
+264.80%
50-day average
55.52
Volume
387.61K
Avg volume
575.09K
Open
63.29
Previous close
61.99
Day's range
61.07 – 63.38
52-week range
14.27 – 70.64
Beta
0.83
Analysts
Strong Buy
Price target
80.75 (+31.6%)
Earnings date
Mar 18, 2027

Key statistics

200-day average
38.58
Enterprise value
1.76B
Price / sales
12.55
Price / book
20.35
Revenue growth
157.90%
Free cash flow
13.96M
Total cash
55.63M
Total debt
24.33M
Return on equity
90.62%
Short % of float
9.50%

Fundamental scorecard

12 of 25 checks passed on ETON’s reported financials

ValueGrowthProfitabilityHealthDividend

12of 25 checks passed

  • Value 0 of 5
  • Growth 4 of 5
  • Profitability 3 of 5
  • Financial health 5 of 5
  • Dividend 0 of 5

Statements to Sep 30, 2026.

Financials — quick view

All financials
ETON Revenue — quarterly 57.92M
ETON Net income — quarterly 35.25M
ETON EPS — quarterly 1.23

Earnings

ETON recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Mar 18, 2027Mar 30, 20270.49———
Nov 5, 2026Sep 30, 20260.31250.50+0.19+60.00%
Aug 13, 2026Jun 30, 20260.18980.35+0.16+84.40%
May 14, 2026Mar 31, 20260.100.05-0.05-50.00%
Mar 19, 2026Dec 31, 20250.120.05-0.07-58.33%
Nov 6, 2025Sep 30, 20250.16-0.07-0.23-143.75%

Upgrades / downgrades

ETON analyst upgrades and downgrades
DateFirmActionFromTo
Nov 10, 2026B. Riley SecuritiesmainBuyBuy
Nov 6, 2026Canaccord GenuitymainBuyBuy
Nov 6, 2026HC Wainwright & Co.mainBuyBuy
Oct 14, 2026HC Wainwright & Co.reitBuyBuy
Aug 14, 2026Canaccord GenuitymainBuyBuy
Aug 14, 2026B. Riley SecuritiesreitBuyBuy

About Eton Pharmaceuticals, Inc.

Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing various product candidates, which are in late-stage development, including ET-600 for diabetes insipidus; Amglidia for neonatal diabetes mellitus; ET-700 for Wilson disease; ET-800 for adrenal insufficiency; and ZENEO hydrocortisone autoinjector for adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
United States

News

Your note

Sign in to keep a note on ETON — it syncs with the Stock Master app.

Insider holders

ETON insider holders
InsiderRelationLatest transactionDateShares held
ADAMS JENNIFER MCKIEDirectorConversion of Exercise of derivative securityJun 16, 20260
BRYNJELSEN SEAN EChief Executive OfficerSaleAug 19, 2026961,194
CASAMENTO CHARLES JDirectorConversion of Exercise of derivative securityNov 9, 20260
ERDOGAN-TRINKAUS IPEKOfficerConversion of Exercise of derivative securityNov 9, 20264,081
GRUBER JAMES RChief Financial OfficerSaleAug 19, 2025204,753
KREMPA DAVIDOfficerSaleOct 5, 202643,381

Institution ownership

ETON institution ownership
Holder% heldSharesValueReported
EcoR1 Capital, LLC8.57%2,470,920151.62MSep 29, 2026
Opaleye Management Inc.8.46%2,440,000149.72MSep 29, 2026
Blackrock Inc.7.27%2,095,914128.61MSep 29, 2026
Vanguard Capital Management LLC4.17%1,203,34273.84MSep 29, 2026
Nantahala Capital Management, LLC3.04%875,50753.72MSep 29, 2026
FMR, LLC2.86%823,58750.54MSep 29, 2026

Fund ownership

ETON fund ownership
Holder% heldSharesValueReported
iShares Trust-iShares Russell 2000 ETF2.40%690,94242.40MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund2.37%684,82142.02MJun 29, 2026
OBERWEIS FUNDS-Oberweis Micro-Cap Fund1.68%483,90029.69MJun 29, 2026
Fidelity Securities Fund-Fidelity Small Cap Growth Fund1.52%439,15026.95MAug 30, 2026
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund1.01%292,34217.94MAug 30, 2026
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund0.94%271,07916.63MJun 29, 2026